1,546.00
+5.00
+(0.32%)
At close: January 9 at 5:24:46 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-11,087.00
-11,087.00
-19,996.00
-21,546.00
-21,803.00
Investing Cash Flow
333.00
333.00
-656.00
-380.00
-187.00
Financing Cash Flow
8,590.00
8,590.00
3,724.00
39,795.00
27,355.00
End Cash Position
4,155.00
4,155.00
6,392.00
23,293.00
5,431.00
Capital Expenditure
-23.00
-23.00
-640.00
-536.00
-160.00
Issuance of Capital Stock
5,732.00
5,732.00
5,475.00
43,181.00
21,603.00
Issuance of Debt
4,511.00
4,511.00
--
1,500.00
12,098.00
Repayment of Debt
--
--
--
-3,500.00
-5,000.00
Free Cash Flow
-11,110.00
-11,110.00
-20,636.00
-22,082.00
-21,963.00
12/31/2020 - 6/13/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NLSPW NLS Pharmaceutics AG
0.0162
-6.36%
26CA.BE ImmunityBio Inc
2.3680
-6.70%
MYND.CN MYND Life Sciences Inc.
0.0950
+35.71%
OCEAW Ocean Biomedical, Inc.
0.0306
-7.27%
CGEN.TA Compugen Ltd.
592.00
+4.41%
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0220
-13.39%
ACUT AccuStem Sciences, Inc.
0.3975
+10.11%
CNBX CNBX Pharmaceuticals Inc.
0.0100
+38.89%
APLIF Appili Therapeutics Inc.
0.0240
-1.64%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0780
-2.26%